The growth inhibitory effect of p21 adenovirus on human bladder cancer cells

M C Hall1, Y Li, R C Pong

  • 1Department of Urology, University of Texas Southwestern Medical Center, Dallas 75235-9110, USA.

The Journal of Urology
|February 25, 2000
PubMed
Abstract

Insights

Gene therapy using p21 (WAF-1/CIP1) shows potential for bladder cancer by inducing cell cycle arrest. However, variable cell sensitivity to adenovirus vectors requires further investigation for clinical application.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The protein p21 (WAF-1/CIP1) plays a crucial role in cell cycle regulation.
  • Understanding p21's role in bladder cancer is essential for developing targeted therapies.
  • Gene therapy approaches are being explored for various cancers, including bladder cancer.

Purpose of the Study:

  • To assess p21 (WAF-1/CIP1) as a candidate for human bladder cancer gene therapy.
  • To determine basal p21 expression levels in bladder cancer cell lines.
  • To investigate the response of bladder cancer cells to p21 overexpression via adenovirus infection and its growth inhibition mechanisms.

Main Methods:

  • Utilized five human bladder cancer cell lines and one primary culture.
  • Constructed a recombinant adenovirus vector carrying p21 cDNA under a CMV promoter.
  • Employed a control virus with antisense p21 to mitigate viral toxicity artifacts.

Main Results:

  • Bladder cancer cell lines displayed variable endogenous p21 levels correlating with growth status.
  • Adenovirus-mediated p21 overexpression led to significant but heterogeneous increases in p21 levels.
  • Growth inhibition occurred via G0/G1 cell cycle arrest, not apoptosis, in sensitive cell lines (e.g., WH).
  • T24 cells showed resistance to p21 adenovirus due to poor viral infection, while 253J cells were highly sensitive.

Conclusions:

  • Basal p21 protein expression varies significantly across human bladder cancer cell lines.
  • Adenoviral p21 overexpression can inhibit bladder cancer growth by inducing G0/G1 cell cycle arrest.
  • Heterogeneity in bladder cancer cell sensitivity to adenovirus infection, potentially due to viral receptor differences, has significant implications for gene therapy development.